论文部分内容阅读
目的探讨胃肠道来源转移性卵巢癌临床特点、治疗方法及预后因素。方法对18例胃肠道来源转移性卵巢癌的临床特点、治疗情况、生存情况和预后因素进行回顾性分析,其中12例转移性卵巢癌患者在原发胃肠道肿瘤手术后有9例行静脉化疗,1例行腹腔化疗,2例未行任何化疗;18例转移癌患者均行妇科手术治疗,妇科手术治疗后3例患者因经济困难未进行任何治疗,其余15例患者都采取术后化疗。结果本组18例转移性卵巢癌患者,生存时间为5~25个月,其中13例患者进行了满意的肿瘤细胞减灭术,中位生存期为13个月,5例患者进行非满意的肿瘤细胞减灭术,中位生存期为9个月。结论胃肠道来源转移性卵巢癌病情晚,预后差。
Objective To investigate the clinical characteristics, treatment and prognostic factors of gastrointestinal origin metastatic ovarian cancer. Methods The clinical features, treatment, survival and prognosis of 18 patients with metastatic ovarian cancer with gastrointestinal origin were retrospectively analyzed. Among them, 12 patients with metastatic ovarian cancer had 9 patients after primary gastrointestinal cancer surgery Intravenous chemotherapy, 1 case of intraperitoneal chemotherapy, 2 cases without any chemotherapy; 18 cases of metastatic cancer patients underwent gynecological surgery, 3 patients after gynecological surgery due to financial difficulties without any treatment, and the remaining 15 patients were taken after surgery Chemotherapy. Results The 18 patients with metastatic ovarian cancer had a survival time of 5 to 25 months. Thirteen patients underwent satisfactory cytoreductive surgery with a median survival of 13 months. Five patients were non-satisfied Tumor cytoreductive surgery, the median survival of 9 months. Conclusion Gastrointestinal metastatic ovarian cancer is late and has a poor prognosis.